MMI Narayana Hospital Esteemed Cardiologist Invited as faculty for EuroPCR

Raipur (thestates.news) | Europe PCR is a prestigious international interventional cardiology conference held annually in Paris, with an average attendance of approximately 10,000 cardiologists from around the world. It provides a platform for leading experts, healthcare
professionals, and specialists to gather, share insights, and discuss the latest advancements in cardiovascular interventions.
Dr. Padhi has been invited as faculty for EuroPCR, where he will contribute his expertise to educate the audience on a crucial aspect of cardiovascular care that demands precision and innovative approaches. With his extensive knowledge and experience in the field, he is an invaluable addition to the roster of esteemed faculty set to explore a spectrum of techniques and devices for addressing ST-elevation myocardial infarction (STEMI), from straightforward cases to more complex
This year who marks the presentation of a case performed at MMI Narayana Hospital, where a 60-year-old patient experienced seeding of a hole in the left ventricle after a major heart attack, one of the most complicated heart attacks deviated with supported by cardiac anaesthesia and cardiac surgeons, the procedure was successfully performed, and the patient was discharged on the fourth day post-procedure. Dr. Padhi will present this case and also serve as an interventional faculty
and moderator for the anticipated session on major heart attack complications, particularly STEMI. This is Dr. Padhi’s third invitation as faculty to this prestigious conference and 6 th presentation of case since 2017 in this conference.
Narayana Health is dedicated to delivering exceptional healthcare and contributing to the advancement of medical knowledge. The invitation extended to Dr. Sumanta Shekhar Padhi underscores our commitment to excellence and innovation in the field of cardiology. We are honoured that Dr. Sumanta Shekhar Padhi has been recognized for his expertise and will share his insights at the prestigious EuroPCR, reaffirming our dedication to staying at the forefront of cardiovascular care and contributing to the ongoing dialogue in the medical community.”